Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Porter

Showing results (121-130 of 298) with videos related to

Pageof 30
Sort By:
Pharmaceutical Research|June 18, 2013
Computational prediction of drug solubility in lipid based formulation excipientsLinda C Persson, Christopher J H Porter, William N Charman, et al.
Physiology & Behavior|February 1, 1975
Effects of variable and fixed second-order schedules on schedule-induced polydipsia in the ratJ H Porter, R Arazie, J W Holbrook, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 9, 2011
Preparation, crystallization and preliminary X-ray diffraction analysis of two intestinal fatty-acid binding proteins in the presence of 11-(dansylamino)undecanoic acidAisha Laguerre, Jerome Wielens, Michael W Parker, et al.
Journal of Visualized Experiments : Jove|April 14, 2015
The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transportNatalie L Trevaskis, Luojuan Hu, Suzanne M Caliph, et al.
The Journal of Pharmacy and Pharmacology|July 20, 2010
Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant mediaTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
Pharmaceutical Research|October 31, 2002
Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious ratsRené Holm, Christopher J H Porter, Anette Müllertz, et al.
Current Drug Delivery|June 19, 2009
Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analoguesSuzanne M Caliph, W A Fried Faassen, Gerard M Vogel, et al.
Psychopharmacology|May 11, 2000
Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in ratsJ H Porter, S A Varvel, R E Vann, et al.
Pharmaceutical Research|August 8, 2015
Fatty Acid Binding Proteins Expressed at the Human Blood-Brain Barrier Bind Drugs in an Isoform-Specific MannerGordon S Lee, Katharina Kappler, Christopher J H Porter, et al.
Nature Reviews. Endocrinology|March 17, 2026
Dysfunctional adipose tissue-lymphatic crosstalk in obesityWilliam De Nardo, Andrea Y Chan, Christopher J H Porter, et al.
Pageof 30

Showing results (121-130 of 298) with videos related to

Sort By:
Pageof 30
Pharmaceutical Research|June 18, 2013
Computational prediction of drug solubility in lipid based formulation excipientsLinda C Persson, Christopher J H Porter, William N Charman, et al.
Physiology & Behavior|February 1, 1975
Effects of variable and fixed second-order schedules on schedule-induced polydipsia in the ratJ H Porter, R Arazie, J W Holbrook, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|February 9, 2011
Preparation, crystallization and preliminary X-ray diffraction analysis of two intestinal fatty-acid binding proteins in the presence of 11-(dansylamino)undecanoic acidAisha Laguerre, Jerome Wielens, Michael W Parker, et al.
Journal of Visualized Experiments : Jove|April 14, 2015
The mesenteric lymph duct cannulated rat model: application to the assessment of intestinal lymphatic drug transportNatalie L Trevaskis, Luojuan Hu, Suzanne M Caliph, et al.
The Journal of Pharmacy and Pharmacology|July 20, 2010
Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant mediaTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
Pharmaceutical Research|October 31, 2002
Structured triglyceride vehicles for oral delivery of halofantrine: examination of intestinal lymphatic transport and bioavailability in conscious ratsRené Holm, Christopher J H Porter, Anette Müllertz, et al.
Current Drug Delivery|June 19, 2009
Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analoguesSuzanne M Caliph, W A Fried Faassen, Gerard M Vogel, et al.
Psychopharmacology|May 11, 2000
Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in ratsJ H Porter, S A Varvel, R E Vann, et al.
Pharmaceutical Research|August 8, 2015
Fatty Acid Binding Proteins Expressed at the Human Blood-Brain Barrier Bind Drugs in an Isoform-Specific MannerGordon S Lee, Katharina Kappler, Christopher J H Porter, et al.
Nature Reviews. Endocrinology|March 17, 2026
Dysfunctional adipose tissue-lymphatic crosstalk in obesityWilliam De Nardo, Andrea Y Chan, Christopher J H Porter, et al.
Pageof 30